Steris Plc (STE):企業の財務・戦略的SWOT分析

◆英語タイトル:Steris Plc (STE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13750
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Steris Plc (STE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and barrier solutions. It also provides detergents and skin care products, laboratory testing, linen management and off-site reprocessing, microbial reduction of medical devices, and chemical and biological decontamination technologies for aircraft, buildings, vehicles, and sensitive equipment. Steris offers its products to medical device, healthcare, pharmaceutical, research and laboratory, and defense and industrial markets. The company markets and sells its products through direct sales force, distributors and dealers in the UK and abroad. Steris is headquartered in Derby, the UK.

Steris Plc Key Recent Developments

Feb 11,2019: STERIS announces financial results for fiscal 2019 third quarter
Feb 06,2019: STERIS | US Endoscopy announces full market release of VIA® procedure kits line extensions
Dec 04,2018: STERIS announces targeted restructuring plan
Aug 08,2018: STERIS Announces financial results for fiscal 2019 first quarter
May 09,2018: STERIS Announces Changes to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Steris Plc – Key Facts
Steris Plc – Key Employees
Steris Plc – Key Employee Biographies
Steris Plc – Major Products and Services
Steris Plc – History
Steris Plc – Company Statement
Steris Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Steris Plc – Business Description
Business Segment: Applied Sterilization Technologies
Overview
Performance
Business Segment: Healthcare Products
Overview
Performance
Key Stats
Business Segment: Healthcare Specialty Services
Overview
Performance
Business Segment: Life Sciences
Overview
Performance
Key Stats
Geographical Segment: Others
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
Steris Plc – Corporate Strategy
Steris Plc – SWOT Analysis
SWOT Analysis – Overview
Steris Plc – Strengths
Steris Plc – Weaknesses
Steris Plc – Opportunities
Steris Plc – Threats
Steris Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Steris Plc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Steris Plc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Steris Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 11, 2019: STERIS announces financial results for fiscal 2019 third quarter
Feb 06, 2019: STERIS | US Endoscopy announces full market release of VIA® procedure kits line extensions
Dec 04, 2018: STERIS announces targeted restructuring plan
Aug 08, 2018: STERIS Announces financial results for fiscal 2019 first quarter
May 09, 2018: STERIS Announces Changes to Board of Directors
Apr 17, 2018: INTERPHEX Announces 2018 Exhibitor Award Winners
Mar 31, 2018: STERIS Announces Financial Results for Fiscal 2019 Second Quarter
Feb 07, 2018: STERIS Announces Financial Results for Fiscal 2018 Third Quarter
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Steris Plc, Key Facts
Steris Plc, Key Employees
Steris Plc, Key Employee Biographies
Steris Plc, Major Products and Services
Steris Plc, History
Steris Plc, Subsidiaries
Steris Plc, Joint Venture
Steris Plc, Key Competitors
Steris Plc, Ratios based on current share price
Steris Plc, Annual Ratios
Steris Plc, Annual Ratios (Cont...1)
Steris Plc, Annual Ratios (Cont...2)
Steris Plc, Interim Ratios
Steris Plc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Steris Plc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Steris Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Steris Plc, Performance Chart (2014 - 2018)
Steris Plc, Ratio Charts
Steris Plc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Steris Plc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Steris Plc (STE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diebold Nixdorf, Incorporated:企業の戦略・SWOT・財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CNOOC Ltd (883)-エネルギー分野:企業M&A・提携分析
    Summary CNOOC Limited (CNOOC) is an upstream oil and gas exploration and production company. It engages in exploration, development, production and sale of crude oil and natural gas. In offshore China, the company engages in oil and natural gas exploration, development and production in Bohai, Weste …
  • Pronto Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Pronto Diagnostics Ltd (PDL) is a medical device company that offers molecular diagnostic products and services. The company develops, produces and distributes SNP-detection kits providing assays for detecting polymorphisms in DNA sequences with genetic diseases and predisposition to disease …
  • Erytech Pharma SA (ERYP):製薬・医療:M&Aディール及び事業提携情報
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …
  • Hengeler Mueller Partnerschaft von Rechtsanwalten mbB:企業の戦略的SWOT分析
    Hengeler Mueller Partnerschaft von Rechtsanwalten mbB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key com …
  • RBC Wealth Management:企業の戦略・SWOT・財務分析
    RBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Finox AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Finox AG (Finox), a subsidiary of Richter Gedeon Nyrt, is a drug development and manufacturing company that offers fertility treatment products. The company develops drugs in the field of fertility therapies. Its product portfolio includes biosimilars and patient friendly delivery devices. F …
  • IHI Corp (7013):電力:M&Aディール及び事業提携情報
    Summary IHI Corp (IHI) is a heavy machinery manufacturer. It provides technology oriented products and services to customers in the public, private and industrial sectors across the world. The group designs and manufactures a diverse range of products that includes ships and offshore facilities, str …
  • Cordy Oilfield Services Inc (CKK):石油・ガス:M&Aディール及び事業提携情報
    Summary Cordy Oilfield Services Inc (Cordy) is an oilfield and construction service provider. The company offers construction and environmental services. Its construction services include underground utilities installation and maintenance, pipeline insulation and reclamation, pump jack maintenance, …
  • Polyplex (Thailand) Public Company Limited:企業の戦略・SWOT・財務情報
    Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • ProSiebenSat.1 Media AG (PSM):企業の財務・戦略的SWOT分析
    ProSiebenSat.1 Media AG (PSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • UCB Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary UCB Inc (UCB), a subsidiary of UCB SA, is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, meta …
  • Sime Darby Berhad (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Berhad (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • LyondellBasell Industries NV (LYB):企業の財務・戦略的SWOT分析
    LyondellBasell Industries NV (LYB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Horizon Pharma Plc (HZNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed pro …
  • ITOCHU Corporation:企業のM&A・事業提携・投資動向
    ITOCHU Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ITOCHU Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Imaging Dynamics Company Ltd (IDL):医療機器:M&Aディール及び事業提携情報
    Summary Imaging Dynamics Company Ltd (IDC) is a medical device company that offers medical imaging and digital radiography technology solutions. The company provides detector series, proprietary software and DR series products. Its software products include Magellan medical image processing software …
  • Entellus Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Entellus Medical Inc (Entellus Medical), a subsidiary of Stryker Corp, is a medical device company that offers invasive products for the treatment of chronic sinusitis. The company’s products include multi sinus dilation system, surgical instruments, sinonasal suction and irrigation system, …
  • Biofrontera AG (B8F):医療機器:M&Aディール及び事業提携情報
    Summary Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic kerat …
  • Hengyuan Refining Company Bhd (HENGYUAN):企業の財務・戦略的SWOT分析
    Hengyuan Refining Company Bhd (HENGYUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆